Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Sarcoma 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Castration-resistant Prostate Cancer 2 Urologic Neoplasms 1 Stomach Neoplasms 1 Osteosarcoma 1 Lymphatic Metastasis 1 Ependymoma 1 Colonic Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Breast Neoplasms 1 Bone Neoplasms 1 Adenocarcinoma 1

Interventions

Ifosfamide 30 Methotrexate 27 Doxorubicin 25 Cyclophosphamide 24 Cisplatin 22 Filgrastim 18 Etoposide 17 Gemcitabine 16 Leucovorin 14 Magnetic Resonance Spectroscopy 11 Temozolomide 10 cabozantinib 9 apatinib 9 Specimen Handling 9 Carboplatin 9 fludarabine 8 X-Rays 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Docetaxel 8 Zoledronic Acid 7 Vincristine 7 Sirolimus 7 Radiotherapy 7 Phantoms, Imaging 7 Biopsy 7 Topotecan 6 Mesna 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Osteosarcoma × Metastasectomy × Clear all

NCT06114225 2023-11-02

PROMIS

Ruijin Hospital

Phase 2 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡